Phathom Pharmaceuticals, Inc. (PHAT) › Operating Cash FlowPhathom Pharmaceuticals, Inc. (PHAT) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$1.02M2019: -$36.51M2020: -$69.69M2021: -$148.46M2022: -$146.53M2023: -$137.58M2024: -$266.77M2025: -$166.78M-$166.78M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$166.78M+37.5%2024-$266.77M-93.9%2023-$137.58M+6.1%2022-$146.53M+1.3%2021-$148.46M-113.0%2020-$69.69M-90.9%2019-$36.51M-3468.9%2018-$1.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share